Trump admin ignored concerns over HCQ import from uninspected plants in India, Pak: Fired scientist

A fired American vaccine expert has alleged that the Trump administration ignored the concerns of doctors over the importation of hydroxychloroquine from "uninspected" factories in India and Pakistan and flooded the US with the unproven and potentially dangerous anti-malarial drug to treat coronavirus patients.

Dr Rick Bright led the US government agency trying to develop a vaccine for the deadly coronavirus that has claimed over 71,000 lives and infected over 1.2 million people in America, the worst hit nation.

In a complaint filed on Tuesday before the US Office of Special Counsel, which oversees the protection of whistleblowers, the scientist said he was ousted for questioning the potential of hydroxychloroquine (HCQ), an anti-malaria drug touted by President Donald Trump as a "game changer" for treating COVID-19 patients in America, the worst-hit natio
His attorneys argue that Bright's removal from his post amounts to a violation of the Whistleblower Protection Act, claiming that Bright "has engaged in numerous instances of protected activity."